| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Atara Biotherapeutics, Inc. (ATRA) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 26 sells. ATRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.32M | $14.17M | - | |
| CEO | 143.1K | $1.53M | - | |
| Other | 52.0K | $556.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2018 | Marcus Joel S68 | Director | Sell | 10,000 | $36.35 | $363,500.00 | -56.9% | |
| Nov 7, 2018 | Gallagher Carol Giltner | Director | Sell | 21,374 | $36.38 | $777,586.12 | -19.4% | |
| Nov 1, 2018 | Newell Joe85 | Chief Tech. Operations Officer | Sale+OE | 1,500 | $35.00 | $52,500.00 | -4.5% | |
| Oct 23, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 7,800 | $33.95 | $264,796.00 | -3.3% | |
| Oct 5, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 7,800 | $40.22 | $313,753.00 | -2.9% | |
| Oct 1, 2018 | Newell Joe85 | Chief Tech. Operations Officer | Sale+OE | 1,500 | $41.28 | $61,918.00 | -2.3% | |
| Sep 26, 2018 | Haqq Christopher | EVP, R&D &Chief Scientific Of | Sell | 13,500 | $43.08 | $581,580.00 | -4.5% | |
| Sep 25, 2018 | Haqq Christopher | EVP, R&D &Chief Scientific Of | Sell | 31,500 | $40.17 | $1,265,330.49 | -2.5% | |
| Sep 19, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 7,800 | $39.81 | $310,479.00 | -6.0% | |
| Sep 7, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 7,800 | $39.35 | $306,922.63 | -2.7% |